Compare CE & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CE | AMRX |
|---|---|---|
| Founded | 1918 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 2005 | N/A |
| Metric | CE | AMRX |
|---|---|---|
| Price | $42.48 | $12.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 4 |
| Target Price | ★ $57.33 | $13.25 |
| AVG Volume (30 Days) | ★ 2.1M | 1.7M |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $9,710,000,000.00 | $2,934,959,000.00 |
| Revenue This Year | N/A | $9.99 |
| Revenue Next Year | $0.62 | $6.67 |
| P/E Ratio | ★ N/A | $758.81 |
| Revenue Growth | N/A | ★ 9.50 |
| 52 Week Low | $35.13 | $6.69 |
| 52 Week High | $75.84 | $12.68 |
| Indicator | CE | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.87 | 63.33 |
| Support Level | $39.55 | $12.12 |
| Resistance Level | $45.02 | $12.43 |
| Average True Range (ATR) | 1.86 | 0.31 |
| MACD | 0.38 | -0.03 |
| Stochastic Oscillator | 58.31 | 81.43 |
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.